DEBRISOQUIN SULFATE
Modify Date: 2025-09-11 10:30:26
DEBRISOQUIN SULFATE structure
|
Common Name | DEBRISOQUIN SULFATE | ||
|---|---|---|---|---|
| CAS Number | 581-88-4 | Molecular Weight | 224.27 | |
| Density | N/A | Boiling Point | 309.8ºC at 760 mmHg | |
| Molecular Formula | C10H13N3.1/2H2O4S | Melting Point | 278-280°, 284-285° or 266-268° (H2O) | |
| MSDS | Chinese USA | Flash Point | 141.1ºC | |
| Symbol |
GHS07 |
Signal Word | Warning | |
Use of DEBRISOQUIN SULFATEDebrisoquin (Isocaramidine) hemisulfate is a TMPRSS2 inhibitors that inhibits SARS-CoV-2 entry into human lung cell line by a TMPRSS2-depedent manner, with an IC50 of 22μM. Debrisoquin hemisulfate can be used for antiviral research[1]. |
| Name | debrisoquin sulfate |
|---|---|
| Synonym | More Synonyms |
| Description | Debrisoquin (Isocaramidine) hemisulfate is a TMPRSS2 inhibitors that inhibits SARS-CoV-2 entry into human lung cell line by a TMPRSS2-depedent manner, with an IC50 of 22μM. Debrisoquin hemisulfate can be used for antiviral research[1]. |
|---|---|
| Related Catalog | |
| Target |
Human Endogenous Metabolite |
| Boiling Point | 309.8ºC at 760 mmHg |
|---|---|
| Melting Point | 278-280°, 284-285° or 266-268° (H2O) |
| Molecular Formula | C10H13N3.1/2H2O4S |
| Molecular Weight | 224.27 |
| Flash Point | 141.1ºC |
| Exact Mass | 448.189270 |
| PSA | 189.20000 |
| LogP | 3.78020 |
| InChIKey | SVYNLIRHKQCPNE-UHFFFAOYSA-N |
| SMILES | N=C(N)N1CCc2ccccc2C1.O=S(=O)(O)O |
| Storage condition | -20°C Freezer |
| Water Solubility | H2O: 20 mg/mL with heat |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| HS Code | 2933499090 |
|---|---|
| Summary | 2933499090. other compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Distinct serum metabolomics profiles associated with malignant progression in the KrasG12D mouse model of pancreatic ductal adenocarcinoma.
BMC Genomics 16 Suppl 1 , S1, (2015) Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer deaths worldwide with less than a 6% 5-year survival rate. PDAC is associated with poor prognosis based on the late stage ... |
|
|
A Comprehensive Metabolomic Investigation in Urine of Mice Exposed to Strontium-90.
Radiat. Res. 183 , 665-74, (2015) Internal emitters such as Strontium-90 ((90)Sr) pose a substantial health risk during and immediately after a nuclear disaster or detonation of an improvised device. The environmental persistency and ... |
|
|
Global Metabolomic Identification of Long-Term Dose-Dependent Urinary Biomarkers in Nonhuman Primates Exposed to Ionizing Radiation.
Radiat. Res. 184 , 121-33, (2015) Due to concerns surrounding potential large-scale radiological events, there is a need to determine robust radiation signatures for the rapid identification of exposed individuals, which can then be u... |
Total 265, Current Page 1 of 27
1
2
3
4
5
| 2(1H)-Isoquinolinecarboximidamide, 3,4-dihydro-, sulfate (2:1) |
| Debrisoquin hemisulfate |
| Bis[3,4-dihydroisoquinolin-2(1H)-yl(imino)methanaminium] sulfate |
| debrisoquine sulfate |
| 3,4-Dihydroisoquinoline-2(1H)-carboximidamide sulfate (2:1) |
| 3,4-Dihydro-2(1H)-isoquinolinecarboximidamide sulfate (2:1) |
| Debrisoquin sulfate |
| debrisoquine sulphate |